Multivariate Cox regression analysis, after confounding with other clinicopathologic variables, identified TGIF2 as an independent prognostic risk factor for glioma patients (HR, 2.366; 95% CI, 1.620-3.455; p < 0.001). This evidence concerns the gene TGIF2 and central nervous system cancer.